A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities

Therapeutic monoclonal antibodies (mAbs) blocking immune checkpoints have been mainly used as monotherapy. Recently, combination therapy targeting multiple immune checkpoints has recently been explored to increase anti-cancer efficacy. Particularly, a single molecule targeting more than one checkpoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cui, Xiaopei, Jia, Huifeng, Xin, Hong, Zhang, Lei, Chen, Shi, Xia, Simin, Li, Xue, Xu, Wei, Chen, Xiaofang, Feng, Yujie, Wei, Xiaoyue, Yu, Haijia, Wang, Yanting, Zhan, Yifan, Zhu, Xiangyang, Zhang, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678608/
https://www.ncbi.nlm.nih.gov/pubmed/34925354
http://dx.doi.org/10.3389/fimmu.2021.778978

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8678608/
https://www.ncbi.nlm.nih.gov/pubmed/34925354
http://dx.doi.org/10.3389/fimmu.2021.778978

Ejemplares similares